NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

Exactech Sharpens Focus on Technology with Active Intelligence

Exactech Sharpens Focus on Technology with Active Intelligence

Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, has announced the launch of its Active Intelligence® platform of technologies that spans the entire journey of patient care. The company plans to aggressively expand its smart technology portfolio to better connect surgeons and patients with personalized, data-driven tools.

Active Intelligence defines Exactech’s strategic commitment to helping surgeons better engage with patients and peers, solve challenges with predictive tools and optimize how surgeons perform.

According to Exactech’s Chief Executive Officer Darin Johnson, “For more than 35 years, our company has focused on helping surgeons improve patient outcomes. With Active Intelligence, we are now expanding our strategic focus to deliver a comprehensive platform of uniquely accessible technologies to assist surgeons throughout the entire journey of patient care. Our practical solutions will help monitor patient recovery, connect surgeons and patients and unlock insights that will augment surgeons’ decision making in ways our industry has never seen.”

Exactech will unveil its pipeline of Active Intelligence solutions in the coming days and weeks. The platform builds on ExactechGPS®, the industry’s first and only no-capital-cost navigation system with verified implant placement guidance for both knee and shoulder surgery, and previously announced innovations including the Shoulder Planning App, the VERASENSE® shoulder sensor and the Vantage® Ankle Patient-Specific Instruments.

Exactech will introduce surgeons to Active Intelligence and unveil its near-term pipeline of innovations during a Dec. 3, 2020 webinar. Surgeons may register at www.exac.com/ActiveIntelligenceWebinar.

For more information, visit www.ExactechAI.com.

*ExactechGPS® is manufactured by Blue Ortho and distributed by Exactech, Inc. VERASENSE™ is manufactured by OrthoSensor and distributed by Exactech, Inc.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X